| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3120ae9cab5bb4831f0cc16288966367 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62 |
| filingDate |
2007-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3562f8dba716218e687a428917714953
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90132f85924dfb4d54d5e674ff5b2489
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75a6166aec34154f3a269cc4df66b7b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe724eaa8d4141b083d7ab3aae569fd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ad76c3383a2f481b84e853be1d7b75b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d0d0cbd66d7674a1ce6449b180b530f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55d5759fada8c7438bd2c6d05c9d0f0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d5c165628afe5ead3454735ce981845 |
| publicationDate |
2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0717098-B8 |
| titleOfInvention |
protease-resistant human insulin analogues, pharmaceutical composition and process for their preparation |
| abstract |
protease-resistant human insulin analogues, pharmaceutical composition and process for their preparation. the present invention relates to novel insulin analogues that exhibit resistance to protease, in which at least two amino acids are substituted and/or deleted relative to the precursor insulin molecule. a method for preparing such insulin analogues, insulin preparations containing the insulin analogues of the invention and a method for treating diabetes mellitus using these insulin analogues is also provided. |
| priorityDate |
2006-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |